BR112015028164A2 - probióticos e métodos de uso - Google Patents

probióticos e métodos de uso

Info

Publication number
BR112015028164A2
BR112015028164A2 BR112015028164A BR112015028164A BR112015028164A2 BR 112015028164 A2 BR112015028164 A2 BR 112015028164A2 BR 112015028164 A BR112015028164 A BR 112015028164A BR 112015028164 A BR112015028164 A BR 112015028164A BR 112015028164 A2 BR112015028164 A2 BR 112015028164A2
Authority
BR
Brazil
Prior art keywords
methods
probiotics
severity
microbial infection
lactating mother
Prior art date
Application number
BR112015028164A
Other languages
English (en)
Other versions
BR112015028164B1 (pt
Inventor
Romana Fasano Francesca
Rescigno Maria
Original Assignee
Heinz Co Brands H J Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heinz Co Brands H J Llc filed Critical Heinz Co Brands H J Llc
Publication of BR112015028164A2 publication Critical patent/BR112015028164A2/pt
Publication of BR112015028164B1 publication Critical patent/BR112015028164B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Pediatric Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

resumo: “probióticos e métodos de uso” a presente invenção representa os métodos para o tratamento ou redução da gravidade de uma infecção microbiana em uma criança de uma mãe lactante. as composições compreendendo os produtos alimentícios fermentados por lactobacillus paracasei cba l74, depositário internacional número de acessão lmg p-24778 são administradas a uma grávida ou mãe lactante a fim de tratar ou atenuar a gravidade de uma infecção microbiana em sua descendência.
BR112015028164-8A 2013-05-10 2014-05-09 Usos da bactéria probiótica, lactobacillus paracasei, para tratar uma infecção microbiana e para prevenir ou reduzir a gravidade de uma infecção microbiana BR112015028164B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361821990P 2013-05-10 2013-05-10
US61/821.990 2013-05-10
PCT/US2014/037517 WO2014183050A1 (en) 2013-05-10 2014-05-09 Probiotics and methods of use

Publications (2)

Publication Number Publication Date
BR112015028164A2 true BR112015028164A2 (pt) 2017-07-25
BR112015028164B1 BR112015028164B1 (pt) 2022-02-08

Family

ID=51867774

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015028164-8A BR112015028164B1 (pt) 2013-05-10 2014-05-09 Usos da bactéria probiótica, lactobacillus paracasei, para tratar uma infecção microbiana e para prevenir ou reduzir a gravidade de uma infecção microbiana

Country Status (16)

Country Link
US (3) US9980991B2 (pt)
EP (2) EP3470074B1 (pt)
CN (2) CN110651824A (pt)
AU (2) AU2014262453B2 (pt)
BR (1) BR112015028164B1 (pt)
CA (1) CA2911496C (pt)
DK (2) DK2994150T3 (pt)
ES (2) ES2837384T3 (pt)
HK (1) HK1218247A1 (pt)
MX (2) MX370692B (pt)
NZ (1) NZ714202A (pt)
PL (2) PL3470074T3 (pt)
PT (2) PT3470074T (pt)
RU (2) RU2665637C2 (pt)
TR (1) TR201908066T4 (pt)
WO (1) WO2014183050A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103997899B (zh) 2011-06-20 2016-04-20 H.J.亨氏公司 益生菌组合物和方法
CA2876963C (en) 2012-06-18 2021-07-06 H.J. Heinz Company Gluten-related disorders
CA2911496C (en) 2013-05-10 2023-08-22 H.J. Heinz Company Brands Llc Probiotics and methods of use
EP3897580A4 (en) * 2018-12-19 2022-11-30 Healthy Cow Corporation READY-TO-USE PROBIOTIC COMPOSITIONS AND THEIR USES
CN110305821B (zh) * 2019-08-28 2019-12-17 鲁东大学 副干酪乳杆菌配合car-t细胞治疗应用
US11638726B2 (en) 2019-09-25 2023-05-02 Tall Goods Llc Methods for producing probiotics fortified avian eggs and egg products and formulations thereof
KR102637723B1 (ko) * 2023-08-09 2024-02-19 이대훈 배변 기능 개선용 조성물 및 이를 포함하는 반려동물용 영양제

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1025140A (en) 1905-02-16 1912-05-07 Otis Elevator Co Potential switch.
US1025865A (en) 1910-10-13 1912-05-07 Hampden Watch Company Balance staff and roller for watches.
US1003929A (en) 1911-04-04 1911-09-19 Jacob T Lutz Trace-carrier.
US1024530A (en) 1911-08-02 1912-04-30 John Elmer Smith Watchmaker's tool.
AU555802B2 (en) 1983-07-01 1986-10-09 Microlife Technics, Inc. Fermented foods comprising lactic acid
RU2134583C1 (ru) * 1996-02-29 1999-08-20 Санкт-Петербургская государственная педиатрическая медицинская академия Способ санации женщин с массивной микробной обсемененностью грудного молока
WO1997049303A1 (en) 1996-06-21 1997-12-31 Quest International B.V. Fermentation of fruit products
SE510813C2 (sv) 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
SE522747C2 (sv) 1999-11-18 2004-03-02 Probi Ab Barnmatsprodukt
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
SE0003100D0 (sv) 2000-09-01 2000-09-01 Probi Ab New strains
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
KR100419132B1 (ko) 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
US7303871B2 (en) 2002-02-14 2007-12-04 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
EP1364586A1 (en) 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
CA2490016C (en) * 2002-06-28 2017-08-22 Puleva Biotech, S.A. Probiotic strains, a process for the selection of them, compositions thereof, and their use
US7468193B2 (en) 2003-10-16 2008-12-23 Nestec S.A. Nutritional composition against side effects of chemotherapy or radiotherapy
US20070207132A1 (en) 2003-10-24 2007-09-06 N.V. Nutricia Synbiotic Composition For Infants
US7955834B2 (en) * 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
EP1723951A1 (en) 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
DK1629850T4 (da) 2004-08-24 2013-07-01 Nutricia Nv Næringssammensætning indeholdende ufordøjelige oligosaccharider
CA2598961C (en) 2005-02-28 2016-09-13 N.V. Nutricia Nutritional composition with probiotics
EP2108269A1 (en) 2005-04-13 2009-10-14 Nestec S.A. Infant formula with low dose probiotics and low dose proteins
US20060233772A1 (en) 2005-04-15 2006-10-19 Udo Herz Method for preventing or treating the development of respiratory allergies
EP1714660A1 (en) 2005-04-21 2006-10-25 N.V. Nutricia Uronic acid and probiotics
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
PT1898724E (pt) 2005-07-01 2010-11-26 Nutricia Nv Nutrição infantil com proteínas hidrolisadas
EP1970366A4 (en) 2005-12-08 2010-07-28 Kirin Holdings Kk CLATHRATE DERIVED FROM ISOHUMULONE AND PREPARATION CONTAINING THE SAME CLATHRATE
ES2359255T3 (es) 2006-03-27 2011-05-19 Nestec S.A. Postre congelado enriquecido con proteínas.
WO2007140622A1 (en) 2006-06-09 2007-12-13 Nutravital Inc. Dairy-derived probiotic compositions and uses thereof
WO2008003782A1 (en) 2006-07-07 2008-01-10 Alpro Nv Method for preparing a dairy analogue
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
WO2008153377A1 (en) 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
WO2009067000A1 (en) 2007-11-20 2009-05-28 N.V. Nutricia Composition with synbiotics
CN101451158A (zh) 2007-12-04 2009-06-10 黑龙江大学 副干酪乳杆菌产生的抗菌肽的分离纯化方法
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
MX2010012905A (es) 2008-05-27 2010-12-21 Nestec Sa Probioticos para mejorar la microbiota intestinal.
WO2009151315A1 (en) 2008-06-13 2009-12-17 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
EP2138187A1 (en) 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and infection
WO2010002241A1 (en) 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
WO2010008272A1 (en) 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
CA2737619A1 (en) 2008-09-19 2010-03-25 Nestec S.A. Nutritional support of the immune system during anti-cancer treatment
EP2168444A1 (en) 2008-09-24 2010-03-31 Nestec S.A. Acidified nutritional formula
PT2438821T (pt) 2008-11-03 2020-04-22 Nestle Sa Composição nutricional compreendendo probióticos e melhorando os padrões de sono
EP2452574A1 (en) 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for young infants
CA2745246A1 (en) 2008-12-08 2010-06-17 Nestec S.A. Modulation of infant fat mass
US20100196341A1 (en) * 2009-02-05 2010-08-05 Syngen Biotech Co., Ltd. Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof
CN102378632A (zh) 2009-04-03 2012-03-14 雀巢产品技术援助有限公司 对促进健康的追赶生长的改进
ES2559008T3 (es) 2009-05-11 2016-02-10 Nestec S.A. Bifidobacterium longum NCC2705 no replicante y trastornos inmunitarios
EP2251021B1 (en) 2009-05-11 2012-02-22 Nestec S.A. Prevention and treatment of allergic diarrhoea
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
US20110070334A1 (en) 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
EP2308498A1 (en) 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
ES2691301T3 (es) 2010-03-12 2018-11-26 Compagnie Gervais Danone Bacterias de ácido láctico para la enfermedad celíaca
EP2552464B1 (en) 2010-03-30 2018-02-28 Assistance Publique - Hôpitaux de Paris Use of bifidobacteria for preventing allergy in breastfed infants
WO2011149335A1 (en) 2010-05-25 2011-12-01 N.V. Nutricia Immune imprinting nutritional composition
WO2011148221A1 (en) 2010-05-28 2011-12-01 Compagnie Gervais Danone Lactic acid bacteria for maturation of the enteric nervous system in infants
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
CN102021127B (zh) 2010-07-28 2012-05-30 江南大学 一株副干酪乳杆菌及其应用
EP2449891A1 (en) 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
EP2449890A1 (en) 2010-11-05 2012-05-09 Nestec S.A. Powdered cereal compositions comprising non-replicating probiotic microorganisms
EP2455094A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
EP2452572A1 (en) 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for infants and children
BR112013013777B1 (pt) 2010-12-06 2019-10-29 Nutricia Nv método não terapêutico e composição nutricional para bebês
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
CN103997899B (zh) 2011-06-20 2016-04-20 H.J.亨氏公司 益生菌组合物和方法
WO2013048654A1 (en) 2011-09-28 2013-04-04 Phillips 66 Company Composite solid oxide fuel cell electrolyte
CA2876963C (en) 2012-06-18 2021-07-06 H.J. Heinz Company Gluten-related disorders
CA2911496C (en) 2013-05-10 2023-08-22 H.J. Heinz Company Brands Llc Probiotics and methods of use

Also Published As

Publication number Publication date
ES2729641T3 (es) 2019-11-05
ES2837384T3 (es) 2021-06-30
RU2015150082A (ru) 2017-06-16
MX2015015515A (es) 2016-05-26
CA2911496A1 (en) 2014-11-13
AU2014262453B2 (en) 2019-06-06
US10729733B2 (en) 2020-08-04
PL3470074T3 (pl) 2021-04-06
RU2018129984A (ru) 2019-03-15
EP2994150A4 (en) 2016-11-16
EP2994150B1 (en) 2019-03-06
RU2018129984A3 (pt) 2022-04-06
US20180271920A1 (en) 2018-09-27
EP3470074A1 (en) 2019-04-17
DK3470074T3 (en) 2020-12-14
PT2994150T (pt) 2019-06-14
RU2015150082A3 (pt) 2018-03-05
NZ714202A (en) 2021-07-30
CN110651824A (zh) 2020-01-07
RU2665637C2 (ru) 2018-09-03
BR112015028164B1 (pt) 2022-02-08
PT3470074T (pt) 2020-11-30
MX370692B (es) 2019-12-19
US20170065648A1 (en) 2017-03-09
AU2014262453A1 (en) 2015-12-03
WO2014183050A1 (en) 2014-11-13
US9980991B2 (en) 2018-05-29
CA2911496C (en) 2023-08-22
PL2994150T3 (pl) 2019-09-30
AU2019226131A1 (en) 2019-09-26
DK2994150T3 (da) 2019-06-11
HK1218247A1 (zh) 2017-02-10
MX2019015306A (es) 2020-02-17
CN105209050A (zh) 2015-12-30
CN105209050B (zh) 2019-11-12
EP2994150A1 (en) 2016-03-16
TR201908066T4 (tr) 2019-06-21
AU2019226131B2 (en) 2020-07-16
EP3470074B1 (en) 2020-10-14
US10258656B2 (en) 2019-04-16
US20160113973A1 (en) 2016-04-28

Similar Documents

Publication Publication Date Title
BR132020021160E2 (pt) composição compreendendo um fermentado de bactéria probiótica lactobacillus paracasei cba l74 e uso do mesmo
BR112015028164A2 (pt) probióticos e métodos de uso
MX350325B (es) Bacteria para usarse como un probiotico para aplicaciones nutricionales y medicas.
MX354047B (es) Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori.
MY174541A (en) Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
EA201391500A1 (ru) Синергический противомикробный эффект
BR112014008511A2 (pt) composições nutricionais com fitonutrientes
MX2017016283A (es) Lactobacillus paracasei para la produccion de acido linoleico conjugado, preparaciones nutricionales y farmaceuticas que lo contienen y sus usos.
BR112014030434A2 (pt) método não terapêutico; uso de uma proteína; composição nutricional; e uso da composição nutricional
NZ711956A (en) Rice protein supplements
PH12017502182A1 (en) Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
BR112013011088A2 (pt) composições de cereal em pó compreendendo microorganismos probióticos não replicantes
NZ712603A (en) Composition containing bacterium belonging to genus lactobacillus
MY175195A (en) Nutritional compositions
BR112018003474A2 (pt) bactérias lactobacillus fermentum que reduzem a concentração de acetaldeído
SG11201608730UA (en) Bifidobacterium breve cbt br3 strain for promotion of growth and nutraceutical composition for promotion of growth containing the same
PH12019501439A1 (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
MX2012007970A (es) Proceso para la preparacion de una biomasa que comprende plantaricina y usos de la misma en el campo medico.
WO2017196140A3 (ko) 면역 조절 t 세포를 유도하는 락토코커스 락티스 bfe920 균주를 포함하는 수산양식 기능성 사료 첨가제
RU2015119462A (ru) Штаммы streptococcus thermophilus для лечения инфекции helicobacter pylori
WO2013084070A3 (en) Salmonella vaccine proteins
BR112014004123A2 (pt) micro-organismos das espécies bacteroides xylanisolvens
NZ712617A (en) Bacterium belonging to genus lactobacillus
BR112014002911A2 (pt) linhagem de l. bulgaricus capaz de inibir a adesão de linhagens de h. pylori a células epiteliais
MY175269A (en) Single high dose of mva induces a protective immune response in neonates and infants

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/05/2014, OBSERVADAS AS CONDICOES LEGAIS.